Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Laparoscopic vs open colectomy: outcomes comparison based on large nationwide databases
Gueller U, Jain N, Hervey S, Purves H, Pietrobon R. Laparoscopic vs open colectomy: outcomes comparison based on large nationwide databases. Arch Surg 2003; 138:1179-86.
01.11.2003Laparoscopic vs open colectomy: outcomes comparison based on large nationwide databases
01.11.2003Arch Surg 2003; 138:1179-86
Gueller Ulrich, Jain Nitin, Hervey Sheleika, Purves Harriett, Pietrobon Ricardo
Statistics in medicine
Gueller U, Bühler L, Clavien P. Statistics in medicine. Swiss Med Wkly 2003; 133:521.
11.10.2003Statistics in medicine
11.10.2003Swiss Med Wkly 2003; 133:521
Gueller Ulrich, Bühler L, Clavien P A
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma
Soiffer R, Mihm M, Webb I, Mulligan R, Neuberg D, Hardy S, Clift S, Bueno R, Jaklitsch M, Mentzer S, Duda R, Tanabe K, Singer S, Gillessen Sommer S, Jung K, Haluska F, Hodi F, Dranoff G. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:3343-50.
01.09.2003Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma
01.09.2003Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:3343-50
Soiffer Robert, Mihm Martin, Webb Iain, Mulligan Richard, Neuberg Donna, Hardy Steve, Clift Shirley, Bueno Raphael, Jaklitsch Michael, Mentzer Steven, Duda Rosemary, Tanabe Kenneth, Singer Samuel, Gillessen Sommer Silke, Jung Ken, Haluska Frank, Hodi F Stephen, Dranoff Glenn
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer
Goldhirsch A, Wood W, Gelber R, Coates A, Thürlimann B, Senn H. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:3357-65.
01.09.2003Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer
01.09.2003Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:3357-65
Goldhirsch Aron, Wood William C, Gelber Richard D, Coates Alan S, Thürlimann Beat, Senn Hans-Jörg
Provider Volume of Total Knee Arthroplasties and Patient Outcomes in the HCUP-Nationwide Inpatient Sample
Hervey S, Purves H, Gueller U, Toth A, Vail T, Pietrobon R. Provider Volume of Total Knee Arthroplasties and Patient Outcomes in the HCUP-Nationwide Inpatient Sample. J Bone Joint Surg Am 2003; 85-A:1775-83.
01.09.2003Provider Volume of Total Knee Arthroplasties and Patient Outcomes in the HCUP-Nationwide Inpatient Sample
01.09.2003J Bone Joint Surg Am 2003; 85-A:1775-83
Hervey Sheleika L, Purves Harriett R, Gueller Ulrich, Toth Alison P, Vail Thomas P, Pietrobon Ricardo
Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis
Tolosa E, Melms A, Kurek R, Stevanovic S, Weber E, Schnorrer P, Driessen C, Lautwein A, Denzin L, Wienhold W, Yasuda Y, Li W, Bromme D. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. The Journal of clinical investigation 2003; 112:517-26.
01.08.2003Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis
01.08.2003The Journal of clinical investigation 2003; 112:517-26
Tolosa Eva, Melms Arthur, Kurek Raffael, Stevanovic Stefan, Weber Ekkehard, Schnorrer Petra, Driessen Christoph, Lautwein Alfred, Denzin Lisa K, Wienhold Wolfgang, Yasuda Yoshiyuki, Li Weijie, Bromme Dieter
Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results
Nabholtz J, Bonneterre J, Buzdar A, Robertson J, Thürlimann B. Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results. European journal of cancer (Oxford, England : 1990) 2003; 39:1684-9.
01.08.2003Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results
01.08.2003European journal of cancer (Oxford, England : 1990) 2003; 39:1684-9
Nabholtz J M, Bonneterre J, Buzdar A, Robertson J F R, Thürlimann Beat
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation
Waeber M, Castiglione-Gertsch M, Dietrich D, Thürlimann B, Goldhirsch A, Brunner K, Borner M, Swiss Group for Clinical Cancer Research (SAKK). Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003; 14:1215-21.
01.08.2003Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation
01.08.2003Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003; 14:1215-21
Waeber M, Castiglione-Gertsch M, Dietrich D, Thürlimann Beat, Goldhirsch A, Brunner K W, Borner M M, Swiss Group for Clinical Cancer Research (SAKK)
Acute pericarditis and pleural effusion complicating cytarabine chemotherapy
Gähler A, Hitz F, Hess U, Cerny T. Acute pericarditis and pleural effusion complicating cytarabine chemotherapy. Onkologie 2003; 26:348-50.
01.08.2003Acute pericarditis and pleural effusion complicating cytarabine chemotherapy
01.08.2003Onkologie 2003; 26:348-50
Gähler A, Hitz F, Hess U, Cerny Thomas
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion
Gillessen Sommer S, Dranoff G, Strominger J, Balk S, Taniguchi M, Blumberg R, Luster A, Mach N, Lee F, Exley M, Nieuwenhuis E, Naumov Y, Wilson S. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proceedings of the National Academy of Sciences of the United States of America 2003; 100:8874-9.
22.07.2003CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion
22.07.2003Proceedings of the National Academy of Sciences of the United States of America 2003; 100:8874-9
Gillessen Sommer Silke, Dranoff Glenn, Strominger Jack L, Balk Steven P, Taniguchi Masaru, Blumberg Richard S, Luster Andrew D, Mach Nicolas, Lee Frederick S, Exley Mark A, Nieuwenhuis Edward E S, Naumov Yuri N, Wilson S Brian
Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Gueller U, Nitzsche E, Moch H, Zuber M. Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?. J Natl Cancer Inst 2003; 95:1040-3.
16.07.2003Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
16.07.2003J Natl Cancer Inst 2003; 95:1040-3
Gueller Ulrich, Nitzsche Egbert, Moch Holger, Zuber Markus
Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer
Bösch B, Gueller U, Schnider A, Maurer R, Harder F, Metzger U, Marti W. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 2003; 90:882-8.
01.07.2003Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer
01.07.2003Br J Surg 2003; 90:882-8
Bösch B, Gueller Ulrich, Schnider A, Maurer R, Harder F, Metzger U, Marti W R
Complete remission of third recurrence of acute myeloid leukemia after treatment with imatinib (STI-571)
Schittenhelm M, Aichele O, Kröber S, Brümmendorf T, Kanz L, Denzlinger C. Complete remission of third recurrence of acute myeloid leukemia after treatment with imatinib (STI-571). Leuk Lymphoma 2003; 44:1251-3.
01.07.2003Complete remission of third recurrence of acute myeloid leukemia after treatment with imatinib (STI-571)
01.07.2003Leuk Lymphoma 2003; 44:1251-3
Schittenhelm Marcus, Aichele O, Kröber S M, Brümmendorf T, Kanz L, Denzlinger C
Deficiencies of GM-CSF and interferon gamma link inflammation and cancer
Enzler T, Gillessen Sommer S, Manis J, Ferguson D, Fleming J, Alt F, Mihm M, Dranoff G. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. The Journal of experimental medicine 2003; 197:1213-9.
05.05.2003Deficiencies of GM-CSF and interferon gamma link inflammation and cancer
05.05.2003The Journal of experimental medicine 2003; 197:1213-9
Enzler Thomas, Gillessen Sommer Silke, Manis John P, Ferguson David, Fleming James, Alt Frederick W, Mihm Martin, Dranoff Glenn
Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies
Wiendl H, Tolosa E, Melms A, Lochmüller H, Overkleeft H, Weber E, Morgalla M, Wienhold W, Erfurth S, Krause S, Mitsdörffer M, Lautwein A, Driessen C. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies. Journal of neuroimmunology 2003; 138:132-43.
01.05.2003Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies
01.05.2003Journal of neuroimmunology 2003; 138:132-43
Wiendl Heinz, Tolosa Eva, Melms Arthur, Lochmüller Hanns, Overkleeft Herman S, Weber Ekkehard, Morgalla Matthias, Wienhold Wolfgang, Erfurth Stella, Krause Sabine, Mitsdörffer Meike, Lautwein Alfred, Driessen Christoph
Tumor-associated fibroblasts recruit blood monocytes into tumor tissue
Silzle T, Kreutz M, Dobler M, Brockhoff G, Knuechel R, Kunz-Schughart L. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 2003; 33:1311-20.
01.05.2003Tumor-associated fibroblasts recruit blood monocytes into tumor tissue
01.05.2003Eur J Immunol 2003; 33:1311-20
Silzle Tobias, Kreutz Marina, Dobler Marcus A, Brockhoff Gero, Knuechel Ruth, Kunz-Schughart Leoni A
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial
Betticher D, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Spiliopoulos A, Roth A, Hsu Schmitz S, Tötsch M, Hansen E, Joss C, von Briel C, Schmid R, Pless M, Habicht J, Ris H. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:1752-9.
01.05.2003Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial
01.05.2003Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:1752-9
Betticher Daniel C, Stahel Rolf, Weder Walter, Stupp Roger, Egli Fritz, Furrer Markus, Honegger Hanspeter, Wernli Martin, Cerny Thomas, Spiliopoulos Anastase, Roth Arnaud D, Hsu Schmitz Shu-Fang, Tötsch Martin, Hansen Eva, Joss Christine, von Briel Christian, Schmid Ralph A, Pless Miklos, Habicht James, Ris Hans-Beat
Weekly paclitaxel (Taxol) with or without trastuzumab (Herceptin) in advanced breast cancer: a community-based observation study
von Moos R, Thürlimann B. Weekly paclitaxel (Taxol) with or without trastuzumab (Herceptin) in advanced breast cancer: a community-based observation study. Onkologie 2003; 26:128-32.
01.04.2003Weekly paclitaxel (Taxol) with or without trastuzumab (Herceptin) in advanced breast cancer: a community-based observation study
01.04.2003Onkologie 2003; 26:128-32
von Moos R, Thürlimann Beat
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
Wallgren A, Collins J, Coates A, Price K, Forbes J, Werner I, Fey M, Thürlimann B, Lindtner J, Holmberg S, Castiglione-Gertsch M, Goldhirsch A, Gelber R, Bonetti M, International Breast Cancer Study Group Trials I through VII. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:1205-13.
01.04.2003Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
01.04.2003Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:1205-13
Wallgren A, Collins J, Coates A S, Price K, Forbes J F, Werner I D, Fey M, Thürlimann Beat, Lindtner J, Holmberg S B, Castiglione-Gertsch M, Goldhirsch A, Gelber R D, Bonetti M, International Breast Cancer Study Group Trials I through VII
Thalidomide: from tragedy to promise
von Moos R, Stolz R, Cerny T, Gillessen Sommer S. Thalidomide: from tragedy to promise. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:77-87.
08.02.2003Thalidomide: from tragedy to promise
08.02.2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:77-87
von Moos Roger, Stolz Rahel, Cerny Thomas, Gillessen Sommer Silke